Abstract
Introduction

52
Antibiotic resistance has become an imminent global public health threat and multiple 53 studies have identified resistant bacteria and resistance genes in environmental samples 54 (1, 2) . Water resulting from human activities such as agriculture, healthcare services and 55 from the general population is collected at wastewater treatment plants (WWTPs), turning 56 them into unintentional collection points for antimicrobial drugs, antibiotic-resistant 57 bacteria (ARB) and resistance genes (ARG) (3) . Wastewater treatment processes are not 58 designed to remove ARB and ARG; so WWTPs typically harbor antimicrobials and other 59 agents known to co-select for antibiotic resistance (4,5). These ARB and ARG present in the 60 air and water in and around WWTP may spread depending on proximity to workers and 61 nearby residents, and they are shed into outgoing environmental systems such as rivers and 62 reservoirs (1) . 63
This protocol describes the methodology that we will use to evaluate presence of ARB and 64
ARG from E. coli and other enterobacteriaceae in air and water samples from WWTPs, and 65 to find out especially if these levels are higher in close proximity to WWTPs. To reduce a 66 potential high level of heterogeneity regarding the setting, the type of samples, and the 67 species and strains of bacteria and genes (6, 7), our systematic review will focus specifically 68 on answering the following research question: Are antimicrobial-resistant 69
enterobacteriaceae and antimicrobial resistance genes present (O) in air and water samples 70 (P) taken either near or downstream or downwind or down-gradient from a wastewater 71 treatment plant (E), as compared to air and water samples taken either further away or 72 upstream or upwind or up-gradient from such wastewater treatment plant (C)? Presence of 73
antimicrobial-resistant bacteria and genes will be quantitatively measured by extracting 74 their prevalence or concentration, depending on the reviewed study. 75 applicable knowledge and skills and their responsibilities can be seen in Table 1 . 78 
Eligibility criteria
81
This systematic review will be conducted following the general steps outlined in Fig. 1 , from 82 writing the protocol to extracting the data. We have constructed our research question 83 following the PECO framework ( Table 2 ). Our Population of interest is air and water samples 84 from WWTPs; our Exposure is locations near WWTPs, or downstream/downwind/down-85 gradient from the WWTP in a unidirectional system. Our Comparison group refers to 86 locations far away from the WWTPs, or upstream/upwind/up-gradient from the WWTP in a 87 unidirectional system. Our Outcome is the presence of antimicrobial-resistant bacteria, 88 especially E. coli and other coliforms, and their resistance genes, measured by extracting 89 either their prevalence or concentration in the reported samples, depending on the 90 reviewed study. We expect to retrieve mostly cross-sectional studies. 91
Although we hypothesize that the closer to a WWTP, the higher the quantitative presence of 92 ARB and ARG, a cut-off point for this distance has not been established for anthropogenic 93 sources (8). Therefore, "proximity", "close distance" and other similar terms will not be 94 defined for the purposes of this systematic review. 95 
Sources of information
96
We will perform a thorough and rigorous search of the current literature using several 97 electronic databases, specifically PubMed, EMBASE, the Cochrane database and Web of 98 Science, including its sub-databases such as Biosis Citation Index, Core Collection, Current 99
Contents Connect and Scielo. After having performed preliminary searches, we have realized 100 that before the year 2000 studies about antimicrobial resistance were mostly focused on the 101 clinical setting and not on environmental samples. We have therefore decided to look for all 102 scientific articles with full-texts published in English, German, Spanish, Italian, Portuguese 103 and French, from January 1st 2000 to September 3rd 2018. 104
We will not perform hand-search of journals, conference proceedings, theses or 105 dissertations, nor will we use web search engines (e.g. Google Scholar) as these methods are 106
typically not precise enough, difficult to reproduce and time consuming (9,10). 107 Similar search strategies adapted to other databases will be generated after this one and 115 using the Systematic Review Accelerator web tool (11). 116
Search strategy
Data management 117
Titles and abstracts of identified articles will be imported into EndNote X8. 2 
(Thomson 118
Reuters). The screening process will be done using Rayyan QCRI, a web application to review 119 articles for a systematic review (12). Screening, risk of bias assessment and data extraction 120 will be performed with the help of forms and relational databases in Access 2016 (Microsoft 121
Corporation, Redmond, WA, USA). Statistical analyses, if needed for a meta-analysis of the 122 reviewed literature, will be performed using R for mac version 3.5.0 or higher (13). 123
Study selection
124
Relevance screening 125
The first stage in our systematic review will be the relevance screening. The main objective 126 of this stage is to check if articles comply with the research question and are eligible for 127 further review. Two reviewers will independently assess titles and abstracts of all retrieved 128 articles. Consensus between reviewers will be required and potential conflicts will be 129 resolved in meetings every two weeks during the relevance screening phase. If it is not 130 possible to achieve consensus between the two assigned reviewers, a third reviewer from 131 the team will be consulted as a tie-breaker. This stage will be carried out with the help of a 132 standardized questionnaire based on previous works (6,7,14) and refined for the purposes of 133 our review. This instrument and screening methods will be pre-tested by taking a random 134 sample of n = 30 retrieved abstracts. The main aim of the pre-test is to make sure that there 135 are no misunderstandings from the reviewers regarding the use of the screening tool or the 136 user interface of the software used to track screening. Possible answers to each one of these questions are "Yes", "No" and "It is not clear from the 147 title and abstract." Based on our research question, we will consider articles if they report 148 findings from primary research, collected environmental samples of air and water from a 149 WWTP and report the prevalence or concentration of antibiotic resistance factors -either 150 bacteria or genes-from Enterobacteriaceae. Further, studies will be excluded if they used 151 microbial source tracking techniques because these techniques aim at identifying the source 152 of bacterial isolates or strains in environmental samples and not at comparing the 153 concentration or proportion of resistant isolates in different locations (6, 7). In other words, 154 studies will be included in our systematic review if the answer to questions 1 to 4 is "yes" 155 and to question 5 is "no", and will be excluded if the answer to either of the questions 1 156 through 4 is "no" or the answer to question 5 is "yes". If the title and abstract of the article 157 do not allow us to reach a clear yes/no answer to these questions, we will classify the article 158 as "unclear" and it will remain available for discussion and further clarification. 159
Design screening 160
The next stage is the design screening. The main objective of this stage is to check whether 161 articles considered proximity to a WWTP as an exposure variable, either by comparing 162 proximity to one or more comparison groups or to a range of distances. We will also 163 consider direction from the WWTP in a unidirectional system, e.g. comparing downstream 164 vs. upstream water samples in a river system adjacent to a WWTP. We will additionally 165 check if the article is available in any of the following languages: English, German, Spanish, 166
Italian, Portuguese or French. 167
In order to achieve the main aim of this stage, we will retrieve the full-text document of 168 publications remaining after the relevance screening stage and read only the methods 169 section, omitting the results and conclusions sections. We will use a standardized design1. Does the study implicitly or explicitly define a WWTP as a point source with reference 172
answer to each of the previous questions is "yes". If the answer to any of the questions is 179 "no", the article will be excluded without further consideration. Decision conflicts and 180 articles to which the answer to any of the questions 1 to 3 is "unclear" will be discussed by 181 the two reviewers and inclusion will be decided on a case-by-case basis. Articles that meet 182 inclusion criteria after relevance and design screening will be considered well-suited to 183 answer our research question and will continue onto the next stage, where we will extract 184 the data and appraise the quality of each study. 185
Data extraction 186
Extracting relevant data from each study will facilitate evidence synthesis, interpretation and 187 presentation of results. Data will be independently extracted by the two reviewers and 188 inputted into a relational database structured form that will be pre-piloted with a sample 189 containing 10% of the citations eligible at this stage. A third reviewer will be consulted for 190 arbitration in case of disagreements. 191
We will focus on these main categories for data extraction: (a) type of sample, source and 192 outcome, (b) sample size, (c) statistical parameters in case modelling was used, (d) 193 confounding control, and (e) measure of resistance. Details on the specific values to extract 194 for each of these categories are given in Table 3 . 195 Table 3 . Data to be extracted from each study
Category
Parameter to extract
Descriptive characteristics of the study
• Location of the study
• Study design
Type of sample, source and outcome
• Environmental media or biological sample type tested
• Location of the WWTP where the sample(s) was (were) taken
• Quantity of samples
• Bacterial species and/or genes analyzed the established gold standard. However, this study will inevitable be at risk of bias because it 210 was not blinded. 211
For each publication, our risk of bias assessment will be performed at the study design level 212 and not at the outcome level because we are interested in evaluating if the techniques used 213 in the included studies were sufficient to avoid potential bias or if, on the contrary, bias 214 could have been introduced by design. At least two reviewers will evaluate the risk of bias at 215 each of these domain levels: sample selection bias, information bias, and confounding. 216
Following an adaptation from the Cochrane Collaboration Risk of Bias Tool (15), we will 217 classify risk of bias to each domain as low, high or unclear. Further, we will determine the 218 overall risk of bias for each study as follows: if there is a low risk of bias in all domains, the 219 overall risk of bias will be low. If the risk of bias is unclear in at least one of the three 220 domains, the overall risk of bias will be classified as unclear. Similarly, if the risk of bias for 221 one or more domains is high, the overall risk of bias will be considered high. An overall low 222 risk of bias means that plausible bias is not likely to change results, while an overall high risk 223 of bias means that plausible bias may risk confidence in results. When the overall risk of bias 224 is unclear, it is accepted that there are some doubts about the results. 225
Assessing risk of bias in each domain follows answering a specific question yes/no for each 226 domain when judging different study aspects or methodologies with specific criteria. Criteria 227 for the judgement of "yes" translates into low risk of bias, and vice versa with criteria for the 228 judgement of "no". Criteria will be judged as "unclear" if there is not enough information to 229 reach a yes/no answer. The specific question to be answered at each domain level along 230 with criteria for the judgement of yes, no or unclear is shown in Table 4 . 231
The risk of bias assessment procedure will be pre-tested using a random sample of 10 % of 232 the retrieved articles until this point. The main aim of the pre-test is to make sure that there 233 are no misunderstandings from the reviewers regarding the risk of bias assessment criteria 234 or the relational databases used to track this stage. 235 Time between sampling at all sites is sufficiently close so as to render the outcomes measured at these sites comparable for the sample type in question 2. Criteria for the judgement of "No":
• Sampling locations are selected differently; • Restriction of sample locations is applied differently depending on exposure status 3. Risk of bias will be considered "unclear" if there is not enough information to judge sample selection bias criteria as either "yes" or "no", e.g. if methods for determining sampling locations are not described in enough detail extracted from each of the articles included in our review and our risk of bias assessment. 238
We will provide descriptive characteristics of each of the studies (year, country, WWTP 239 characteristics if available, type of sample collected) and of their outcomes (examined 240 bacteria or genes, relevant comparison methods, relevant findings including effect 241 measures), as well as our judgement for the risk of bias assessment and the reason(s) for 242 that given judgement. If there is an enough number of high-quality studies with a relatively 243 low level of heterogeneity among effect measures, we will pool findings into a fixed-effects 244 or random-effects meta-analysis and report these results using forest and funnel plots. 245
Discussion
246
In this protocol, we have described our planned methodology to conduct a rigorous revision 247 and synthesis of the published literature regarding the prevalence or concentration of 248 antibiotic-resistant enterobacteria and resistance genes in air and water samples around 249
WWTPs. Our pre-specified criteria for searching the literature, screening relevant articles, 250 assessing risk of bias and extracting and presenting findings will guide us through all of the 251 steps of our review and help us avoid introducing bias a posteriori. 252
We can however anticipate some a priori sources of bias for our review. Some studies only 253 appear in conference proceedings and do not reach a journal publication stage. Excluding 254 conference proceedings puts our review at risk of containing publication bias. However, 255 conference proceedings usually show only a short abstract of each study, which does not 256 allow proper screening or assessment, making these procedures time-consuming and often 257 leading to fruitless results (10). Further, hand-searching of journals, conference proceedings 258 and the use of web search engines (e.g. Google scholar) is laborious, time-consuming, and 259 seldom improves the quality of systematic reviews (9). We expect our methods to ensure 260 reproducibility while maintaining appropriate levels of sensitivity and specificity. Another 261 foreseeable source of bias comes from our language restriction, which may introduce bias 262 and lower precision. However, previous meta-analyses on the impact of language bias in 263 systematic reviews and meta-analyses of controlled trials have found that excluding trials 264 published in languages other than English has a little effect on summary treatment effect 265 estimates (16, 17) . Therefore, by including English and other Indo-European languages as a 266 criterion for inclusion, we minimize introducing language bias. 267
To our knowledge, there are at least two previously published systematic reviews with 268 similar questions to ours (6,7). These highly informative works present a high level of study 269 heterogeneity that prevented pooling results. We believe that our systematic review will 270
give an update and will allow to draw more precise results focusing only on antibiotic-271 resistant enterobacteria and resistance genes in air and water samples around WWTPs. 272
Further, we aim at widening our search of this more specific research question by using a 273 different set of databases, including EMBASE, the Cochrane database, Web of Science and its 274 sub-databases, thus providing a broader understanding of the research question focused on 275 antibiotic-resistant enterobacteria and resistance genes in air and water samples around 276
WWTPs. 277
Although our planned systematic review is in the field of environmental sciences, it is highly 278 related to health-related outcomes. Antibiotic-resistant enterobacteria and resistance genes 279 found in environmental samples around WWTPs may pose a risk to the health status and 280 well-being of WWTP workers and nearby residents. Quantifying the prevalence or 281 concentration of antibiotic-resistant bacteria and genes in anthropogenic sources will 282 improve our understanding of the magnitude of the risk to which humans are exposed. In 283 addition, our study results will provide guidance and support for planning future studies and 284 in the end to establish further requirements for the usage of antimicrobial drugs, and for the 285 treatment of wastewater polluted with antibiotic-resistant bacteria and resistance genes. 286 
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